Axcelis Technologies, Inc. $ACLS Holdings Lifted by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. grew its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLSFree Report) by 111.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,747 shares of the semiconductor company’s stock after buying an additional 7,775 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Axcelis Technologies were worth $1,440,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in ACLS. American Century Companies Inc. increased its position in Axcelis Technologies by 45.5% in the 2nd quarter. American Century Companies Inc. now owns 1,659,463 shares of the semiconductor company’s stock valued at $115,648,000 after acquiring an additional 518,968 shares during the period. Boston Partners grew its stake in shares of Axcelis Technologies by 42.3% in the second quarter. Boston Partners now owns 474,043 shares of the semiconductor company’s stock worth $33,616,000 after purchasing an additional 141,004 shares in the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Axcelis Technologies by 1,344.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 109,628 shares of the semiconductor company’s stock valued at $10,388,000 after purchasing an additional 102,040 shares during the period. Reinhart Partners LLC. increased its holdings in shares of Axcelis Technologies by 6.0% during the third quarter. Reinhart Partners LLC. now owns 1,610,332 shares of the semiconductor company’s stock valued at $157,234,000 after purchasing an additional 91,788 shares during the period. Finally, Balyasny Asset Management L.P. bought a new stake in shares of Axcelis Technologies during the second quarter valued at about $6,324,000. 89.98% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Gerald M. Blumenstock sold 3,034 shares of the company’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $89.46, for a total transaction of $271,421.64. Following the completion of the sale, the executive vice president directly owned 18,661 shares of the company’s stock, valued at $1,669,413.06. This represents a 13.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jorge Titinger sold 2,000 shares of the stock in a transaction on Wednesday, December 17th. The shares were sold at an average price of $86.05, for a total value of $172,100.00. Following the completion of the transaction, the director owned 7,477 shares of the company’s stock, valued at $643,395.85. This trade represents a 21.10% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.48% of the stock is owned by insiders.

Axcelis Technologies Trading Up 4.4%

Axcelis Technologies stock opened at $94.55 on Friday. The firm has a market cap of $2.90 billion, a price-to-earnings ratio of 22.35 and a beta of 1.77. Axcelis Technologies, Inc. has a 1 year low of $40.40 and a 1 year high of $102.93. The firm’s 50 day moving average price is $88.23 and its two-hundred day moving average price is $85.09. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.32 and a current ratio of 4.95.

Analyst Ratings Changes

A number of equities analysts recently issued reports on ACLS shares. B. Riley Financial increased their target price on shares of Axcelis Technologies from $84.00 to $94.00 and gave the company a “neutral” rating in a research report on Wednesday, January 21st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Monday, December 22nd. Zacks Research cut shares of Axcelis Technologies from a “strong-buy” rating to a “hold” rating in a report on Friday, December 5th. Wall Street Zen cut Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Saturday, January 3rd. Finally, Bank of America upped their target price on Axcelis Technologies from $90.00 to $100.00 and gave the stock an “underperform” rating in a research report on Tuesday, January 13th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $102.25.

Get Our Latest Stock Analysis on Axcelis Technologies

Axcelis Technologies Profile

(Free Report)

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.

Recommended Stories

Institutional Ownership by Quarter for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.